Company
Headquarters: Tokyo, Japan
Employees: 3,291
CEO: Mr. Kotaro Fukuda
¥244.01 Billion
JPY as of Jan. 1, 2024
US$1.73 Billion
Company | Market Cap (USD) |
---|---|
Abbott | $192.67 B |
Stryker Corporation | $113.24 B |
Medtronic | $111.60 B |
Boston Scientific Corporation | $85.22 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Fukuda Denshi Co., Ltd. develops, manufactures, and sells medical electronic equipment worldwide. It provides resting electrocardiograph products; data management software; stress test products; Holter products and software; and patient monitoring systems, including central and bedside monitors, digital transmitters, and central viewer workstations. The company also offers defibrillator monitors; and ultrasound systems, as well as vascular screening systems. Fukuda Denshi Co., Ltd. was founded in 1939 and is based in Tokyo, Japan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Fukuda Denshi Co. Ltd has the following listings and related stock indices.
Stock: JPX: 6960 wb_incandescent